secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evolent Health, Inc. (EVH)
CIK:        0001628908
Form:       8-K
Filed at:   2023-05-03T23:59:59+00:00
Accession:  0001628908-23-000061
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evolent Health Q1 rev. $427.7M (+44%), adj. EBITDA $50.5M; names new COO
------------------------------------------------------------------------

- Revenue $427.7M (+44% YoY); net loss $26.3M; Adj. EBITDA $50.5M (11.8% margin).
- Total Lives on Platform 65.6M, up from 17.9M YoY; average unique members 41.3M.
- Expanded oncology solution with Centene; national payer agreement with AMSURG for surgical management.
- COO Steve Tutewohl departing July 3; Emily Rafferty appointed COO effective same date.
- CEO Seth Blackley expressed confidence in 2023 outlook and 2024 EBITDA run-rate target.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628908/000162890823000061/0001628908-23-000061-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628908/000162890823000061/evh-20230503.htm
  HTML page:      https://secwatch.observer/filing/0001628908-23-000061

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer